David González

8.4k total citations · 2 hit papers
71 papers, 2.8k citations indexed

About

David González is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, David González has authored 71 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in David González's work include Chronic Lymphocytic Leukemia Research (14 papers), Cancer Genomics and Diagnostics (14 papers) and Sarcoma Diagnosis and Treatment (14 papers). David González is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Cancer Genomics and Diagnostics (14 papers) and Sarcoma Diagnosis and Treatment (14 papers). David González collaborates with scholars based in United Kingdom, Spain and Canada. David González's co-authors include Andrew Wotherspoon, David Cunningham, Clare Peckitt, Andrew G. Nicholson, Alicia Okines, Sanjay Popat, Alexandra Rice, John Swansbury, Ian Chau and Digby Elliott and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

David González

69 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

2013 547 citations Thomas K. Waddell, Ian Chau et al. The Lancet Oncology profile →
Mismatch Repair Deficiency, Microsatellite Instability, and Survival

2017 365 citations Andrew Wotherspoon, Clare Peckitt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David González United Kingdom	24	1.4k	1.1k	806	558	525	71	2.8k
Ludwine Messiaen United States	39	892 0.6×	491 0.4×	661 0.8×	213 0.4×	375 0.7×	145	5.0k
Torsten Pietsch Germany	31	731 0.5×	466 0.4×	191 0.2×	1.5k 2.7×	358 0.7×	78	3.4k
Rosalie E. Ferner United Kingdom	41	1.2k 0.8×	256 0.2×	872 1.1×	674 1.2×	706 1.3×	90	6.1k
Willemina M. Molenaar Netherlands	30	1.2k 0.8×	515 0.5×	260 0.3×	231 0.4×	519 1.0×	90	2.4k
Athena M. Cherry United States	29	396 0.3×	654 0.6×	399 0.5×	512 0.9×	365 0.7×	81	4.7k
Elisabeth Mangold Germany	36	291 0.2×	1.2k 1.1×	1.9k 2.3×	239 0.4×	482 0.9×	117	4.0k
Maria Grazia Tibiletti Italy	29	212 0.1×	812 0.7×	810 1.0×	255 0.5×	234 0.4×	93	2.3k
D C Brown United Kingdom	17	385 0.3×	550 0.5×	345 0.4×	142 0.3×	297 0.6×	31	2.0k
Sean Preston United Kingdom	15	253 0.2×	496 0.4×	246 0.3×	171 0.3×	596 1.1×	25	1.6k
Richard L. Bakst United States	28	665 0.5×	946 0.8×	238 0.3×	351 0.6×	1.1k 2.0×	156	3.1k

Countries citing papers authored by David González

Since Specialization

Citations

This map shows the geographic impact of David González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David González more than expected).

Fields of papers citing papers by David González

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David González. The network helps show where David González may publish in the future.

Co-authorship network of co-authors of David González

This figure shows the co-authorship network connecting the top 25 collaborators of David González. A scholar is included among the top collaborators of David González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David González. David González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stevens, Wendy B.C., Peter Stewart, Leonie I. Kroeze, et al.. (2025). Mutational profile dynamics in follicular lymphoma and large cell transformation. Journal of Clinical Pathology. 78(7). 473–482. 1 indexed citations

Ferrari, Gérson, et al.. (2025). Overview of systematic reviews on behavioral determinants of physical activity and healthy eating in schoolchildren. Scientific Reports. 15(1). 35379–35379. 2 indexed citations

Catherwood, Mark, et al.. (2024). Initiation of molecular testing of endometrial carcinomas in a population‐based setting: practical considerations and pitfalls. Histopathology. 86(4). 611–626. 3 indexed citations

Passmore, Steven, et al.. (2022). Differing Characteristics of Human-Shaped Visual Stimuli Affect Clinicians’ Dosage of a Spinal Manipulative Thrust on a Low-Fidelity Model: A Cross-Sectional Study. Journal of Manipulative and Physiological Therapeutics. 45(3). 171–178. 3 indexed citations

González, David, et al.. (2022). Circadian rhythm shifts and alcohol access in adolescence synergistically increase alcohol preference and intake in adulthood in male C57BL/6 mice. Behavioural Brain Research. 438. 114216–114216. 5 indexed citations

González, David, et al.. (2021). Pupillometry provides a psychophysiological index of arousal level and cognitive effort during the performance of a visual-auditory dual-task in individuals with a history of concussion. Vision Research. 184. 43–51. 9 indexed citations

Houghton, Oisín, Peter Stewart, Chang H. Kim, et al.. (2020). A novel next generation sequencing approach to improve sarcoma diagnosis. Modern Pathology. 33(7). 1350–1359. 19 indexed citations

Beck, Katja, Louise Harewood, Peter Stewart, et al.. (2020). Detection of Structural Variants in Circulating Cell-Free DNA from Sarcoma Patients Using Next Generation Sequencing. Cancers. 12(12). 3627–3627. 13 indexed citations

Catherwood, Mark, David González, David Donaldson, et al.. (2019). Relevance of TP53 for CLL diagnostics. Journal of Clinical Pathology. 72(5). 343–346. 11 indexed citations

10.

Niechwiej‐Szwedo, Ewa, et al.. (2018). Evaluation of the Leap Motion Controller during the performance of visually-guided upper limb movements. PLoS ONE. 13(3). e0193639–e0193639. 41 indexed citations

11.

Moorcraft, Sing Yu, David González, & Brian A. Walker. (2015). Understanding next generation sequencing in oncology: A guide for oncologists. Critical Reviews in Oncology/Hematology. 96(3). 463–474. 29 indexed citations

12.

Angulo, Bárbara, Fernando López‐Ríos, & David González. (2014). A new generation of companion diagnostics: cobasBRAF, KRASandEGFRmutation detection tests. Expert Review of Molecular Diagnostics. 14(5). 517–524. 20 indexed citations

13.

Alpár, Donát, Dörte Wren, Luca Ermini, et al.. (2014). Clonal origins of ETV6-RUNX1+ acute lymphoblastic leukemia: studies in monozygotic twins. Leukemia. 29(4). 839–846. 38 indexed citations

14.

Waddell, Thomas K., Ian Chau, David Cunningham, et al.. (2013). Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. The Lancet Oncology. 14(6). 481–489. 547 indexed citations breakdown →

15.

Pospı́šilová, Šárka, David González, Jitka Malčíková, et al.. (2012). ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia. 26(7). 1458–1461. 133 indexed citations

16.

González, David, Monica Else, Dörte Wren, et al.. (2012). CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes. Haematologica. 98(2). 274–278. 14 indexed citations

17.

Hostein, Isabelle, Maria Dêbiec‐Rychter, David González, et al.. (2011). A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours. Journal of Gastroenterology. 46(5). 586–594. 18 indexed citations

18.

Nutt, J E, K O’Toole, David González, & John Lunec. (2009). Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines. European Journal of Cancer. 45(9). 1684–1691. 17 indexed citations

19.

Bódi, István, et al.. (2008). Meningeal alveolar soft part sarcoma confirmed by characteristic ASPCR1‐TFE3 fusion. Neuropathology. 29(4). 460–465. 12 indexed citations

20.

Catherwood, Mark, et al.. (2006). Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin’s lymphomas with high rates of somatic hypermutation. Journal of Clinical Pathology. 60(5). 524–528. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact